|
1
|
DeSantis CE, Siegel RL, Sauer AG, Miller
KD, Fedewa SA, Alcaraz KI and Jemal A: Cancer statistics for
African Americans, 2016: Progress and opportunities in reducing
racial disparities. CA Cancer J Clin. 66:290–308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zheng R, Zeng H, Zhang S, Chen T and Chen
W: National estimates of cancer prevalence in China, 2011. Cancer
Lett. 370:33–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Waggoner SE: Cervical cancer. Lancet.
361:2217–2225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Crosbie EJ, Einstein MH, Franceschi S and
Kitchener HC: Human papillomavirus and cervical cancer. Lancet.
382:889–899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hildesheim A, Gonzalez P, Kreimer AR,
Wacholder S, Schussler J, Rodriguez AC, Porras C, Schiffman M,
Sidawy M, Schiller JT, et al: Impact of human papillomavirus (HPV)
16 and 18 vaccination on prevalent infections and rates of cervical
lesions after excisional treatment. Am J Obstet Gynecol.
215:212.e1–212.e15. 2016. View Article : Google Scholar
|
|
7
|
Rodríguez-Carunchio L, Soveral I,
Steenbergen RD, Torné A, Martinez S, Fusté P, Pahisa J, Marimon L,
Ordi J and del Pino M: HPV-negative carcinoma of the uterine
cervix: A distinct type of cervical cancer with poor prognosis.
BJOG. 122:119–127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gutschner T and Diederichs S: The
hallmarks of cancer: A long non-coding RNA point of view. RNA Biol.
9:703–719. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qi P and Du X: The long non-coding RNAs, a
new cancer diagnostic and therapeutic gold mine. Mod Pathol.
26:155–165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang Y, Zhu X, Xu Y, Tang Q, Huang Z, Zhao
Z, Lu J, Song G, Xu H, Deng C and Wang J: Energy stress-induced
lncRNA HAND2-AS1 represses HIF1α-mediated energy metabolism and
inhibits osteosarcoma progression. Am J Cancer Res. 8:526–537.
2018.PubMed/NCBI
|
|
12
|
Yang X, Wang CC, Lee WYW, Trovik J, Chung
TKH and Kwong J: Long non-coding RNA HAND2-AS1 inhibits invasion
and metastasis in endometrioid endometrial carcinoma through
inactivating neuromedin U. Cancer Lett. 413:23–34. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei L, Surma M, Shi S, Lambert-Cheatham N
and Shi J: Novel insights into the roles of Rho kinase in cancer.
Arch Immunol Ther Exp (Warsz). 64:259–278. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kardani K, Agi E and Bolhassani A:
Diagnosis of HPV Infections, HPV Testing in Patients. HPV
Infections: Diagnosis, Prevention, and Treatment. Bolhassani:
Bentham Science Publishers Ltd. (Sharjah). 129–158. 2018.
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Friedlander M and Grogan M; U.S.
Preventative Services Task Force, : Guidelines for the treatment of
recurrent and metastatic cervical cancer. Oncologist. 7:342–347.
2002.PubMed/NCBI
|
|
17
|
Symonds RP, Gourley C, Davidson S, Carty
K, McCartney E, Rai D, Banerjee S, Jackson D, Lord R, McCormack M,
et al: Cediranib combined with carboplatin and paclitaxel in
patients with metastatic or recurrent cervical cancer (CIRCCa): A
randomised, double-blind, placebo-controlled phase 2 trial. Lancet
Oncol. 16:1515–1524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Whatcott CJ, Ng S, Barrett MT, Hostetter
G, Von Hoff DD and Han H: Inhibition of ROCK1 kinase modulates both
tumor cells and stromal fibroblasts in pancreatic cancer. PLoS One.
12:e01838712017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chin VT, Nagrial AM, Chou A, Biankin AV,
Gill AJ, Timpson P and Pajic M: Rho-associated kinase signalling
and the cancer microenvironment: Novel biological implications and
therapeutic opportunities. Expert Rev Mol Med. 17:e172015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui M, Wang J, Li Q, Zhang J, Jia J and
Zhan X: Long non-coding RNA HOXA11-AS functions as a competing
endogenous RNA to regulate ROCK1 expression by sponging miR-124-3p
in osteosarcoma. Biomed Pharmacother. 92:437–444. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Zeng X, Wang N, Zhao W, Zhang X,
Teng S, Zhang Y and Lu Z: Long noncoding RNA DANCR, working as a
competitive endogenous RNA, promotes ROCK1-mediated proliferation
and metastasis via decoying of miR-335-5p and miR-1972 in
osteosarcoma. Mol Cancer. 17:892018. View Article : Google Scholar : PubMed/NCBI
|
